See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Jan. 10, 2007

Osteoarthritis or Hypertension (High Blood Pressure) Healthy Patient Studies Sexual Dysfunction

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Osteoarthritis or Hypertension (High Blood Pressure)

If you have both osteoarthritis (OA) and high blood pressure, you may qualify for this study. Participants 50 or older must have OA of the hand, hip, knee, or spine and be taking medication to control high blood pressure.

The research site is in Gainesville, Fla.

More information

Please see http://www.centerwatch.com/patient/studies/cat109.html or http://www.centerwatch.com/patient/studies/cat85.html.

-----

Healthy Patient Studies

This study will evaluate an investigational medication to treat human respiratory syncytial virus (RSV), which can infect the airway tract. Non-smoking volunteers 18-45 who are height/weight proportionate and available for up to six overnight stays and one outpatient visit may be eligible.

The research site is in Tacoma, Wash.

More information

Please see http://www.centerwatch.com/patient/studies/phasei.html.

-----

Sexual Dysfunction

This study will evaluate whether an investigational medication is safe and effective in treating hypoactive sexual desire disorder, when taken orally either once or twice daily. Female volunteers 18 to 45 in general good health who are concerned about a decrease in their sexual desire may be eligible.

The research site is in Wheat Ridge, Colo.

More information

Please see http://www.centerwatch.com/patient/studies/cat333.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.